1 completed, 1 withdrawn. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Withdrawn 1 |
Follow Reference: new trials by email Literature Review of Reference trials Research Report on Reference
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunogenicity Assessment of Peg-filgrastim vs. Neulasta® as Adjunct to Chemotherapy in Patients With Breast Cancer Lupin's Pegfilgrastim, Neulasta® - Breast Cancer | Phase 4 | Completed | Lupin Ltd. | 138 | 2018-03-06 | 2021-06-15 |
| Post-cesarean Pain Control Via Continuous Infusion of Ropivacain et Diclogenac Into the Wound Versus Intathecal Morphine Reference, Experimental - Cesarean Section | Phase 4 | Withdrawn | Centre Hospitalier Universitaire de Nīmes | 2010-09-01 | 2026-06-17 |
Breast Neoplasms (1) · Pain (1)
Centre Hospitalier Universitaire de Nīmes (1) · Lupin Ltd. (1)
India (1)
Antoinie Guy Aya, MD (1) · Dhananjay Bakhle, MD (1)
2008 (1)